Tue, January 24, 2023

Matthew Harrison Maintained (BLUE) at Sell with Increased Target to $4 on, Jan 24th, 2023

Matthew Harrison of Morgan Stanley, Maintained "bluebird bio, Inc." (BLUE) at Sell with Increased Target from $3 to $4 on, Jan 24th, 2023.

Matthew has made no other calls on BLUE in the last 4 months.



There are 2 other peers that have a rating on BLUE. Out of the 2 peers that are also analyzing BLUE, all agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Decreased Target to $8 on, Monday, January 23rd, 2023
  • Luca Issi of "RBC Capital" Maintained at Hold with Decreased Target to $8 on, Tuesday, November 8th, 2022